Tissue Regeneration Contributing Large Share In The Acellular Dermal Matrices Market

 Acellular Dermal Matrices Market

The Acellular Dermal Matrices Market is estimated to be valued at US$ 8.8 Bn in 2023 and is expected to exhibit a CAGR of 12.1% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
Acellular dermal matrices are processed cadaveric acellular dermal matrices used for soft tissue reinforcement and replacement in plastic and reconstructive surgeries such as breast reconstruction and hernia repair. They offer advantages such as biocompatibility, biodegradability, cost-effectiveness and lower risk of rejection or infection compared to autologous dermal grafts. The products fill voids, facilitate wound healing and provide matrix for neovascularization and tissue integration.

Market key trends:
One of the major trends driving the growth of the acellular dermal matrices market is the increased usage of these products in soft tissue repair procedures. According to the American Society for Aesthetic Plastic Surgery, nearly 313,735 breast reconstruction procedures were performed in the United States in 2021. Acellular dermal matrices are widely used in breast reconstruction to fill the voids under the skin flaps and provide scaffold for tissue regeneration. Furthermore, hernia repair surgery market is also growing rapidly, especially in developing countries, owing to rising geriatric population and lifestyle diseases. Acellular dermal matrices help reinforce the thin abdominal wall tissue and prevent recurrence of hernia. Their versatile applications along with soft tissue repair benefits will continue fueling the demand over the forecast period.

Porter's Analysis

Threat of new entrants: Low capital requirement for starting acellular dermal matrices manufacturing limits the threat of new entrants. However, established suppliers have significant brand recognition and distribution networks.

Bargaining power of buyers: Large group purchasing organizations and integrated healthcare systems have significant bargaining power over suppliers in the market.

Bargaining power of suppliers: A few major companies dominate the supply of acellular dermal matrices, giving them strong bargaining power over buyers.

Threat of new substitutes: Ongoing research has potential to develop new regenerative matrices that could substitute acellular dermal matrices.

Competitive rivalry: Intense competition exists between major suppliers to gain market share.

SWOT Analysis

Strengths: Growing demand for reconstructive surgeries and advancement in tissue engineering drive the Acellular Dermal Matrices Market growth.

Weaknesses: High production cost and lack of skilled professionals restrict the market growth.

Opportunities: Untapped developing markets and ongoing R&D in tissue regeneration present new opportunities.

Threats: Stringent regulatory approval process and reimbursement issues challenge the market.

Key Takeaways

The global acellular dermal matrices market is expected to witness high growth at a CAGR of 12.1% over the forecast period due to rising incidence of breast reconstruction surgeries.

The US market holds the highest share and is expected to retain its dominance over the forecast period. Growing awareness about cosmetic breast reconstruction surgeries drives the US market.

The Asia Pacific region is anticipated to exhibit the fastest growth over 2023-2030. Increasing healthcare expenditure and medical tourism in countries like China, India promotes the regional market growth.

Key players operating in the acellular dermal matrices market are Integra LifeSciences Corporation, AbbVie Inc., Johnson & Johnson, HansBioMed, Becton, Dickinson and Company, Cook Group, Smith & Nephew Plc., Reprise Biomedical, Organogenesis Holdings Inc., Tissue Regenix, LifeNet Health, Zimmer Biomet Holdings, Inc., Stryker Corporation, MiMedx Group, PolyNovo Limited, Fidia Pharma USA Inc., Baxter International Inc., In2Bones Global, BioHorizons, Inc., Harbor MedTech, Inc., MLM Biologics Inc., Geistlich Pharma AG, Olaregen Therapeutix, Inc., EnColl Corporation, Kerecis limited, DSM, ACell Inc., 3M, Cell Constructs I, LLC, CG bio Inc., and Marine Polymer Technologies, Inc.

Read More : https://www.marketwebjournal.com/acellular-dermal-matrices-market-opportunities-analysis-size-share/


 

Comments

Post a Comment

Popular posts from this blog

Location-Based Services Market to Reach US$ 32,210 Million in 2022

Image
Location-Based Services Market Market Overview: The global Location-Based Services (LBS) Market is estimated to be valued at US$ 32,210 Million In 2022 and is expected to exhibit a CAGR of 18.7% over the forecast period from 2023 to 2030. Location-Based Services enable businesses and organizations to provide personalized services and target customers based on their real-time geographic location. These services offer benefits such as increased customer engagement, improved operational efficiency, and enhanced decision-making. The need for Location-Based Services is driven by the growing adoption of smartphones and the increasing demand for location-aware applications in various industries including retail, healthcare, transportation, and hospitality. Market Key Trends: One key trend in the Location-Based Services Market is the integration of LBS with Internet of Things (IoT) technology. The convergence of LBS and IoT allows businesses to track and monitor assets in real-time, enablin...
Read more

Precision Medicine Market to Reach US$ 73,946.2 Million In 2022: Coherent Market Insights

Image
Precision Medicine Market The global Precision Medicine Market is projected to reach a value of US$ 73,946.2 Million In 2022 , with a CAGR of 10.3% over the forecast period 2022-2030, according to a new report by Coherent Market Insights. Market Overview: Precision Medicine involves personalized treatment plans and therapies based on an individual's genetic makeup, lifestyle, and environment. It offers several advantages, such as improved treatment outcomes, minimized adverse effects, and targeted therapy for complex diseases. The need for Precision Medicine is increasing due to rising cases of chronic and genetic diseases, increasing healthcare expenditure, and advancements in genomics technology. Market Key Trends: One key trend in the Precision Medicine Market is the use of genomic sequencing. Genomic sequencing refers to the process of determining the complete DNA sequence of an individual. It plays a crucial role in identifying genetic variations and mutations that can be t...
Read more

The Evolution And Growth Of The Europe E-Bike Market: A Journey Towards Sustainable Mobility

Image
Europe E-Bike Market In recent years, the Europe E-bike Market has witnessed a remarkable transformation, reflecting the continent's commitment to sustainable and eco-friendly transportation solutions. Electric bikes, or e-bikes, have emerged as a popular choice for commuters and outdoor enthusiasts alike, bridging the gap between traditional bicycles and motorized vehicles. This paper explores the evolution of the Europe e-bike market, delving into its factors driving growth, market trends, regulatory landscape, environmental impact, and the challenges and opportunities it presents. The roots of e-bikes can be traced back to the late 19th century, but it was only in the last two decades that they gained significant traction in Europe. Factors such as increasing urbanization, traffic congestion, rising environmental awareness, and technological advancements in battery and electric motor technologies played a pivotal role in their popularity. E-bikes offered an efficient and sust...
Read more